The Insight Partners published latest research report on “Antibiotics Market Share Report, Size, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class; Action Mechanism, and Geography” the global market size was valued at USD 44,111.31 million in 2020 and is projected to reach USD 59,253.24 million in 2028; it is expected to grow at a CAGR of 4% during 2021–2028.
The Insight Partners published latest research report on “Antibiotics Market Share Report, Size, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class; Action Mechanism, and Geography” the global market size was valued at USD 44,111.31 million in 2020 and is projected to reach USD 59,253.24 million in 2028; it is expected to grow at a CAGR of 4% during 2021–2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00003406
Rising Prevalence of Bacterial Infections is expected to drive the Global Antibiotics Market Growth:
The prevalence of infectious diseases especially caused by bacteria is increasing day by day worldwide. According to a study published by the American Society for Microbiology (ASM) in 2019, 1.5–4.5 million infections across the world are caused by the Carbapenem-resistant bacterial strains belonging to the Enterobacteriaceae group every year. Additionally, the same risk factor leads to ~49,000 hospitalization cases in the US every year. According to a study published by UNICEF, in 2018, pneumonia was the cause for ~1,755,000 deaths among children below the age of five; moreover, ~1,200,000 children lost their lives by diarrhea around the globe. Further, according to a study published by the NCBI in 2018, campylobacteria infection, which is transmitted through the consumption of poultry, is one of the leading causes of bacterial foodborne infections in developed countries, which is causing a major economic burden. According to estimates given by the World Health Organization (WHO) in 2018, every year, nearly 33 million people die of campylobacteria’s worldwide. Such exponential increase in prevalence of bacterial infections is expected to continue to drive the growth of antibiotics market during the forecast period. Thus, the increasing prevalence of such drug-resistant bacteria compels the manufacturers and R&D faculties to come up with new variants of antimicrobials effective against the new, as well as old, bacterial strains, thereby fueling the growth of the antibiotics market.
Based on action mechanism, the antibiotics market has been segmented into cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors, mycolic acid inhibitors, and others. The cell wall synthesis inhibitors segment held the largest share of the market in 2020; whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR of 5.2% in the market during the forecast period. Such growing prevalence of infectious disease in different regions across the world is raising the global demand for the antibiotics.
Directly Purchase Premium Copy of Antibiotics Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003406
Global Antibiotics Market Report Scope, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 44,111.31 Million in 2020 |
| Market Size Value by | USD 59,253.24 Million by 2028 |
| Growth rate | CAGR of 4% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 161 |
| No. of Tables | 49 |
| No. of Charts & Figures | 70 |
| Historical data available | Yes |
| Segments covered | Drug Class; Action Mechanism, and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Pfizer, Inc, Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals), Abbott, GlaxoSmithKline Plc, Sanofi, Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Astellas Pharma |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 161 pages with 49 list of tables & 70 list of figures from the report, “Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Geography” in detail along with the table of contents: https://www.theinsightpartners.com/reports/antibiotics-market
Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterial which include a range of powerful drugs and are used to treat diseases caused by bacteria.
Market leaders operating in the market have undertaken various organic growth strategies in the antibiotics Market. The antibiotics market majorly consists of the players such as Sanofi., Novartis AG., Pfizer Inc, Bayer AG, Johnson & Johnson Services, Inc, Bristol-Myers Squibb Company, Astellas Pharma Inc, Abbott, Eli Lilly and Company among others. Several organic approaches, such as product launches, and expansion/relocation in the antibiotics Market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
Growth Strategies by the Players operating in the Global Antibiotics Market:
Dec 2016 - Pfizer Inc. announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca’s late-stage small molecule anti-infective business, primarily outside the United States. The agreement includes the commercialization and development rights to the newly approved EU drug Zavicefta (ceftazidime-avibactam), the marketed agents Merrem/Meronem (meropenem) and Zinforo (ceftaroline fosamil), and the clinical development assets aztreonam-avibactam (ATM-AVI) and CXL.
May 2017 - Pfizer’s lauched new antibiotic for multidrug resistant (MDR) infections - Zavicefta - in the UK and Germany, its first EU markets.
July 2019 - The company has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.
September 2019 - Astellas Pharma Inc.Announces Launch of Dafclir Tablets for the Treatment of Infectious Enteritis Caused by Clostridium difficile in Japan. It is likely to increase the action of selective antibacterial spectrum
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Antibiotics and Antimycotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Systemic Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Peptide Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Antibiotic Resistance Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Animal Antibacterial and Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Aminoglycoside Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/antibiotics-market